Get a Deep Insight into the World Market for Prescription Cardiovascular Drugs

Posted on: Wednesday, 5 December 2007, 09:00 CST

Reportlinker.com announces that a new market research report related to the Cardiovascular disease sector is available in its catalogue.

The World Market for Prescription Cardiovascular Drugs

To order that report:

www.reportlinker.com/p062949/The-World-Market-for -Prescription-Cardiovascular-Drugs.html

(Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)

As one of the most competitive pharmaceutical markets, keeping track of the cardiovascular drug market can be a difficult undertaking. The range of therapeutic options available to physicians has expanded significantly in the past few years, and will continue to increase with a robust pipeline.

The World Market for Cardiovascular Drugs Market is designed to steer marketers through the sheer size and diversity of the current market and the potential of new products that will make this therapeutic category among the most competitive of prescription drug segments.

Analyst Mary Ann Crandall considers both the exisitng products and the pipeline in this comprehensive market study.

The following market segments are covered:

Cardiac Glycosides and Positive Inotropic Agents

Antihypertensive Agents (ACE Inhibitors, Angiotensin II Receptor Antagonists, Adrenergic Blockers, Beta Blockers, Calcium Channel Blockers, Combinations)

Antiarrhythmic Agents (Class I, Class II, Class III)

Vasodilators and Peripheral Vasodilator Agents

Antihyperlipidemic Agents (Bile Acid Sequestrants, Fibric Acid Derivatives, Statins, Nicotonic Acid)

Blood Moadifiers (Anticoagulants, Antiplatelets, Thrmbolytics)

Diuretic Agents (Carbonic Anhydrase Inhibitors, Loop, Potassium-Sparing, Thiazides)

Other Cardiovascular Agents

Specific diseases and disorders discussed include:

Angina

Arrhythmia

Atherosclerosis

Congestive heart failure

Coronary artery disease

Hypertension

Myocardial infarction

Other disorders

The report details the various categories of cardiovascular drugs and describes U.S. and non-U.S. markets in each of the specific cardiovascular drug areas. Revenues are considered in each subsegment according to type of drug. In addition, top products in each category are reviewed. The report also covers market drivers and trends that are influencing the market, including:

Obesity Epidemic and Heart Disease

Statin use

Inflammation Reduction

Unique Drug Combinations

Hormone Therapy and Cardiovascular Disease Risks

CAD Risk Factor Differences in Sexes

Women and Heart Disease

OTC Statins

Genetic Research and Wafarin Use

Future Trends in the Pharmaceutical Arena

The report further identifies major market factors, which are discussed in detail, and a total market summary is presented.

All market data are presented at the manufacturers' level. Data are expressed in current U.S. dollars. The base year for data was 2004. Historical data are provided for 2002 and 2003, and forecast data are provided for each of the years 2005 through 2009. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2004 base year.

* CHAPTER ONE: EXECUTIVE SUMMARY Introduction

* Scope and Methodology

* Size and Growth of the Market

* Issues and Trends Affecting Market

* Leading Competitors

* CHAPTER TWO: INTRODUCTION Overview of the Cardiovascular System

* Heart

* Circulatory System

* Cardiac Cycle

* Isovolumic Contraction

* Ventricular Ejection

* Isovolumic Relaxation

* Coronary Circulation

* Cardiac Myocytes

* Contraction

* Calcium Role in Contraction

* Relaxation

* Cardiac Energy Metabolism

* Cardiac Output

* Cardiovascular Disorders

* Angina

* Incidence